An AI-powered wearable platform
Revolutionizing epilepsy care through advanced detection and real-time alerts enabling proactive prevention of nighttime SUDEP for safer and more restful nights
How It Works
At Neurava, we envision a world where we are not only reliably detecting seizure frequency, severity and cardiorespiratory dysfunctions, but also predicting their onset and stratifying SUDEP risk, enabling a data-driven approach to care management that starts at home. We are working every day to make this vision a reality.
Nighttime Monitoring Through
A1
Seizure activity
N1
Cardiac, respiration, and oxygen saturation activity
Phone App
AI Algorithms
Incorporating novel features and biomarkers
Neurava Cloud
data storage and processing
Physician Portal
+
Instant Alert
We will instantly alert your caregivers and EMS should the need arise.
How it works
At Neurava, we envision a world where we are not only reliably detecting seizure frequency, severity and cardiorespiratory dysfunctions, but also predicting their onset and stratifying SUDEP risk, enabling a data-driven approach to care management that starts at home. We are working every day to make this vision a reality.
1
Nighttime Monitoring
A1
Seizure activity
N1
Cardiorespiratory activity
Bluetooth
Bluetooth
Internet
2
Phone App
Medication history, notes, alerts, reports.
AI Algorithms
Incorporating novel features and biomarkers
3
Neurava Cloud
Data storage & overviews
+Instant Alert
We will instantly alert your caregivers and EMS should the need arise.
Physician Portal: Comprehensive insights into retrospective data
Progress Highlights
We’ve come forward leaps and bounds since our founders pioneered Neurava’s vision to help those with epilepsy take back control of their lives
A1 usability study completed
Multiple seizures captured, including a near SUDEP seizure, with good usability scores
Algorithms with industry leading performance
Results from our algorithm development processes support industry-leading performance for seizure and cardiorespiratory dysfunction detection with a low false alert rate
A1+N1 usability study in adults and children with epilepsy completed
Multiple seizures with induced cardiorespiratory dysfunctions captured. Data will be used to identify features and biomarkers to support Neurava’s AI-based algorithms
Commercial manufacturing
Neurava invested in developing a scalable supply chain to support commercial manufacturing of our wearable platform
FDA pre-submissions completed
Neurava’s wearable platform was introduced to FDA and its regulatory approach de-risked
Publications
A near-SUDEP case study, highlighting our wearables’ value proposition, was recently published, with more to come in 2025
Subscribe to get our updates
Get in Touch
Are you impacted by epilepsy, a healthcare professional, a researcher, an innovator, a company, or an investor seeking breakthrough medical technology? Let's connect!
contactAddress
HQ: 101 W Dickman St
Suite 807
Baltimore, MD 21230
Information
Follow Us
© Neurava Inc. 2025 All Rights Reserved
designed & built by arcxne